Cargando…

The acute inflammatory response to intranigral α-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation

BACKGROUND: Activated microglia are a feature of the host response to neurodegeneration in Parkinson's disease (PD) and are thought to contribute to disease progression. Recent evidence suggests that extracellular α-synuclein (eSNCA) may play an important role in the pathogenesis of PD and that...

Descripción completa

Detalles Bibliográficos
Autores principales: Couch, Yvonne, Alvarez-Erviti, Lydia, Sibson, Nicola R, Wood, Matthew JA, Anthony, Daniel C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3239418/
https://www.ncbi.nlm.nih.gov/pubmed/22122884
http://dx.doi.org/10.1186/1742-2094-8-166
_version_ 1782219182997241856
author Couch, Yvonne
Alvarez-Erviti, Lydia
Sibson, Nicola R
Wood, Matthew JA
Anthony, Daniel C
author_facet Couch, Yvonne
Alvarez-Erviti, Lydia
Sibson, Nicola R
Wood, Matthew JA
Anthony, Daniel C
author_sort Couch, Yvonne
collection PubMed
description BACKGROUND: Activated microglia are a feature of the host response to neurodegeneration in Parkinson's disease (PD) and are thought to contribute to disease progression. Recent evidence suggests that extracellular α-synuclein (eSNCA) may play an important role in the pathogenesis of PD and that this may be mediated by a microglial response. METHODS: We wished to discover whether the host response to eSNCA would be sufficient to induce significant cytokine production. In vitro cultured BV-2 microglia were used to determine the basic inflammatory response to eSNCA. In vivo, 8-week old Biozzi mice were subjected to a single intranigral injection of either 3 μg SNCA, lipopolysaccharide (LPS) or serum protein (BSA) and allowed to recover for 24 hours. A second cohort of animals were peripherally challenged with LPS (0.5 mg/kg) 6 hours prior to tissue collection. Inflammation was studied by quantitative real-time PCR for a number of pro-inflammatory genes and immunohistochemistry for microglial activation, endothelial activation and cell death. RESULTS: In vitro data showed a robust microglial response to SNCA, including a positive NFĸB response and the production of pro-inflammatory cytokines. Direct injection of SNCA into the substantia nigra resulted in the upregulation of mRNA expression of proinflammatory cytokines, the expression of endothelial markers of inflammation and microglial activation. However, these results were significantly different to those obtained after direct injection of LPS. By contrast, when the animals were injected intracerebrally with SNCA and subsequently challenged with systemic LPS, the level of production of IL-1β in the substantia nigra became comparable to that induced by the direct injection of LPS into the brain. The injection of albumin into the nigra with a peripheral LPS challenge did not provoke the production of a significant inflammatory response. Direct injection of LPS into the substantia nigra also induces cell death in a more robust manner than direct injection of either SNCA or BSA. CONCLUSION: These results suggest that the presence of eSNCA protein 'primes' microglia, making them susceptible to environmental proinflammatory challenge. For this reason, we hypothesise that where 'inflammation' contributes to the disease progression in PD, it does so in a punctuate manner (on-off) as a result of systemic events.
format Online
Article
Text
id pubmed-3239418
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32394182011-12-16 The acute inflammatory response to intranigral α-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation Couch, Yvonne Alvarez-Erviti, Lydia Sibson, Nicola R Wood, Matthew JA Anthony, Daniel C J Neuroinflammation Research BACKGROUND: Activated microglia are a feature of the host response to neurodegeneration in Parkinson's disease (PD) and are thought to contribute to disease progression. Recent evidence suggests that extracellular α-synuclein (eSNCA) may play an important role in the pathogenesis of PD and that this may be mediated by a microglial response. METHODS: We wished to discover whether the host response to eSNCA would be sufficient to induce significant cytokine production. In vitro cultured BV-2 microglia were used to determine the basic inflammatory response to eSNCA. In vivo, 8-week old Biozzi mice were subjected to a single intranigral injection of either 3 μg SNCA, lipopolysaccharide (LPS) or serum protein (BSA) and allowed to recover for 24 hours. A second cohort of animals were peripherally challenged with LPS (0.5 mg/kg) 6 hours prior to tissue collection. Inflammation was studied by quantitative real-time PCR for a number of pro-inflammatory genes and immunohistochemistry for microglial activation, endothelial activation and cell death. RESULTS: In vitro data showed a robust microglial response to SNCA, including a positive NFĸB response and the production of pro-inflammatory cytokines. Direct injection of SNCA into the substantia nigra resulted in the upregulation of mRNA expression of proinflammatory cytokines, the expression of endothelial markers of inflammation and microglial activation. However, these results were significantly different to those obtained after direct injection of LPS. By contrast, when the animals were injected intracerebrally with SNCA and subsequently challenged with systemic LPS, the level of production of IL-1β in the substantia nigra became comparable to that induced by the direct injection of LPS into the brain. The injection of albumin into the nigra with a peripheral LPS challenge did not provoke the production of a significant inflammatory response. Direct injection of LPS into the substantia nigra also induces cell death in a more robust manner than direct injection of either SNCA or BSA. CONCLUSION: These results suggest that the presence of eSNCA protein 'primes' microglia, making them susceptible to environmental proinflammatory challenge. For this reason, we hypothesise that where 'inflammation' contributes to the disease progression in PD, it does so in a punctuate manner (on-off) as a result of systemic events. BioMed Central 2011-11-28 /pmc/articles/PMC3239418/ /pubmed/22122884 http://dx.doi.org/10.1186/1742-2094-8-166 Text en Copyright ©2011 Couch et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Couch, Yvonne
Alvarez-Erviti, Lydia
Sibson, Nicola R
Wood, Matthew JA
Anthony, Daniel C
The acute inflammatory response to intranigral α-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation
title The acute inflammatory response to intranigral α-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation
title_full The acute inflammatory response to intranigral α-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation
title_fullStr The acute inflammatory response to intranigral α-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation
title_full_unstemmed The acute inflammatory response to intranigral α-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation
title_short The acute inflammatory response to intranigral α-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation
title_sort acute inflammatory response to intranigral α-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3239418/
https://www.ncbi.nlm.nih.gov/pubmed/22122884
http://dx.doi.org/10.1186/1742-2094-8-166
work_keys_str_mv AT couchyvonne theacuteinflammatoryresponsetointranigralasynucleindifferssignificantlyfromintranigrallipopolysaccharideandisexacerbatedbyperipheralinflammation
AT alvarezervitilydia theacuteinflammatoryresponsetointranigralasynucleindifferssignificantlyfromintranigrallipopolysaccharideandisexacerbatedbyperipheralinflammation
AT sibsonnicolar theacuteinflammatoryresponsetointranigralasynucleindifferssignificantlyfromintranigrallipopolysaccharideandisexacerbatedbyperipheralinflammation
AT woodmatthewja theacuteinflammatoryresponsetointranigralasynucleindifferssignificantlyfromintranigrallipopolysaccharideandisexacerbatedbyperipheralinflammation
AT anthonydanielc theacuteinflammatoryresponsetointranigralasynucleindifferssignificantlyfromintranigrallipopolysaccharideandisexacerbatedbyperipheralinflammation
AT couchyvonne acuteinflammatoryresponsetointranigralasynucleindifferssignificantlyfromintranigrallipopolysaccharideandisexacerbatedbyperipheralinflammation
AT alvarezervitilydia acuteinflammatoryresponsetointranigralasynucleindifferssignificantlyfromintranigrallipopolysaccharideandisexacerbatedbyperipheralinflammation
AT sibsonnicolar acuteinflammatoryresponsetointranigralasynucleindifferssignificantlyfromintranigrallipopolysaccharideandisexacerbatedbyperipheralinflammation
AT woodmatthewja acuteinflammatoryresponsetointranigralasynucleindifferssignificantlyfromintranigrallipopolysaccharideandisexacerbatedbyperipheralinflammation
AT anthonydanielc acuteinflammatoryresponsetointranigralasynucleindifferssignificantlyfromintranigrallipopolysaccharideandisexacerbatedbyperipheralinflammation